Literature DB >> 27036853

Incorporation of phosphate into glycogen by glycogen synthase.

Christopher J Contreras1, Dyann M Segvich1, Krishna Mahalingan1, Vimbai M Chikwana2, Terence L Kirley3, Thomas D Hurley1, Anna A DePaoli-Roach1, Peter J Roach4.   

Abstract

The storage polymer glycogen normally contains small amounts of covalently attached phosphate as phosphomonoesters at C2, C3 and C6 atoms of glucose residues. In the absence of the laforin phosphatase, as in the rare childhood epilepsy Lafora disease, the phosphorylation level is elevated and is associated with abnormal glycogen structure that contributes to the pathology. Laforin therefore likely functions in vivo as a glycogen phosphatase. The mechanism of glycogen phosphorylation is less well-understood. We have reported that glycogen synthase incorporates phosphate into glycogen via a rare side reaction in which glucose-phosphate rather than glucose is transferred to a growing polyglucose chain (Tagliabracci et al. (2011) Cell Metab13, 274-282). We proposed a mechanism to account for phosphorylation at C2 and possibly at C3. Our results have since been challenged (Nitschke et al. (2013) Cell Metab17, 756-767). Here we extend the evidence supporting our conclusion, validating the assay used for the detection of glycogen phosphorylation, measurement of the transfer of (32)P from [β-(32)P]UDP-glucose to glycogen by glycogen synthase. The (32)P associated with the glycogen fraction was stable to ethanol precipitation, SDS-PAGE and gel filtration on Sephadex G50. The (32)P-signal was not affected by inclusion of excess unlabeled UDP before analysis or by treatment with a UDPase, arguing against the signal being due to contaminating [β-(32)P]UDP generated in the reaction. Furthermore, [(32)P]UDP did not bind non-covalently to glycogen. The (32)P associated with glycogen was released by laforin treatment, suggesting that it was present as a phosphomonoester. The conclusion is that glycogen synthase can mediate the introduction of phosphate into glycogen, thereby providing a possible mechanism for C2, and perhaps C3, phosphorylation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glycogen; Glycogen synthase; Lafora; Laforin; Phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 27036853      PMCID: PMC4843132          DOI: 10.1016/j.abb.2016.03.020

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  39 in total

1.  A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.

Authors:  J A Thomas; K K Schlender; J Larner
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

2.  The presence of phosphate in glycogen.

Authors:  J D Fontana
Journal:  FEBS Lett       Date:  1980-01-01       Impact factor: 4.124

3.  The role of phosphate in muscle glycogen.

Authors:  J Lomako; W M Lomako; B R Kirkman; W J Whelan
Journal:  Biofactors       Date:  1994-05       Impact factor: 6.113

4.  Laforin and malin deletions in mice produce similar neurologic impairments.

Authors:  Ana M García-Cabrero; Ainhoa Marinas; Rosa Guerrero; Santiago Rodríguez de Córdoba; José M Serratosa; Marina P Sánchez
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

5.  Cloning, expression, and characterization of a soluble calcium-activated nucleotidase, a human enzyme belonging to a new family of extracellular nucleotidases.

Authors:  Thomas M Smith; Carrie A Hicks-Berger; Sunkyu Kim; Terence L Kirley
Journal:  Arch Biochem Biophys       Date:  2002-10-01       Impact factor: 4.013

6.  A UDP-glucose:glycoprotein glucose-1-phosphotransferase in embryonic chicken neural retina.

Authors:  L A Koro; R B Marchase
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

7.  Glycogen contains phosphodiester groups that can be introduced by UDPglucose: glycogen glucose 1-phosphotransferase.

Authors:  J Lomako; W M Lomako; W J Whelan; R B Marchase
Journal:  FEBS Lett       Date:  1993-08-30       Impact factor: 4.124

Review 8.  Protein tyrosine phosphatases in the human genome.

Authors:  Andres Alonso; Joanna Sasin; Nunzio Bottini; Ilan Friedberg; Iddo Friedberg; Andrei Osterman; Adam Godzik; Tony Hunter; Jack Dixon; Tomas Mustelin
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

9.  Functional characterization of alpha-glucan,water dikinase, the starch phosphorylating enzyme.

Authors:  René Mikkelsen; Lone Baunsgaard; Andreas Blennow
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

10.  Mutations in NHLRC1 cause progressive myoclonus epilepsy.

Authors:  Elayne M Chan; Edwin J Young; Leonarda Ianzano; Iulia Munteanu; Xiaochu Zhao; Constantine C Christopoulos; Giuliano Avanzini; Maurizio Elia; Cameron A Ackerley; Nebojsa J Jovic; Saeed Bohlega; Eva Andermann; Guy A Rouleau; Antonio V Delgado-Escueta; Berge A Minassian; Stephen W Scherer
Journal:  Nat Genet       Date:  2003-09-07       Impact factor: 38.330

View more
  9 in total

Review 1.  Structural biology of glucan phosphatases from humans to plants.

Authors:  Matthew S Gentry; M Kathryn Brewer; Craig W Vander Kooi
Journal:  Curr Opin Struct Biol       Date:  2016-08-04       Impact factor: 6.809

Review 2.  Lafora disease offers a unique window into neuronal glycogen metabolism.

Authors:  Matthew S Gentry; Joan J Guinovart; Berge A Minassian; Peter J Roach; Jose M Serratosa
Journal:  J Biol Chem       Date:  2018-02-26       Impact factor: 5.157

3.  A novel EPM2A mutation yields a slow progression form of Lafora disease.

Authors:  Maria Adelaida Garcia-Gimeno; Pilar Natalia Rodilla-Ramirez; Rosa Viana; Xavier Salas-Puig; M Kathryn Brewer; Matthew S Gentry; Pascual Sanz
Journal:  Epilepsy Res       Date:  2018-07-21       Impact factor: 3.045

Review 4.  Lafora Disease: A Review of Molecular Mechanisms and Pathology.

Authors:  Brandy Verhalen; Susan Arnold; Berge A Minassian
Journal:  Neuropediatrics       Date:  2018-10-18       Impact factor: 1.947

Review 5.  Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.

Authors:  M Kathryn Brewer; Matthew S Gentry
Journal:  Adv Neurobiol       Date:  2019

6.  Generation and characterization of a laforin nanobody inhibitor.

Authors:  Zoe R Simmons; Savita Sharma; Jeremiah Wayne; Sheng Li; Craig W Vander Kooi; Matthew S Gentry
Journal:  Clin Biochem       Date:  2021-04-05       Impact factor: 3.625

7.  Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.

Authors:  Felix Nitschke; Mitchell A Sullivan; Peixiang Wang; Xiaochu Zhao; Erin E Chown; Ami M Perri; Lori Israelian; Lucia Juana-López; Paola Bovolenta; Santiago Rodríguez de Córdoba; Martin Steup; Berge A Minassian
Journal:  EMBO Mol Med       Date:  2017-07       Impact factor: 12.137

8.  Regulatory Functions of Nilaparvata lugens GSK-3 in Energy and Chitin Metabolism.

Authors:  Yan-Juan Ding; Guo-Yong Li; Cai-Di Xu; Yan Wu; Zhong-Shi Zhou; Shi-Gui Wang; Can Li
Journal:  Front Physiol       Date:  2020-11-25       Impact factor: 4.566

9.  Silencing of Glycogen Synthase Kinase 3 Significantly Inhibits Chitin and Fatty Acid Metabolism in Asian Citrus Psyllid, Diaphorina citri.

Authors:  Jin-Bo Zhang; Zhan-Jun Lu; Hai-Zhong Yu
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.